An Israeli perishable personal device for identifying the Corona received FDA approval

A perishable personal device for identifying the corona of an Israeli entrepreneur last night received an emergency permit from the US Food and Drug Administration (FDA). Visby Medical has announced that it has received approval for the company's personal and disposable PCR device, which is used for rapid detection of COVID-19 disease; The hand-sized device is capable of delivering extremely reliable results in less than 30 minutes.
Visby was founded by Adam de la Zerda, who also serves as the company's CEO, a graduate of the Technion in Computer Engineering. It is reported that the first commercial application of the technology it has developed will be launched as part of the war on the Corona virus. In order to ensure that the corona test results reach their destination in the best possible way.
The PCR technique is a process of exponential replication of DNA or RNA. By controlled heating and cooling of samples in the presence of specially designed enzymes, billions of copies of the desired genetic material are created. Without this amplification process, a sample with a small viral load - such as one obtained from an asymptomatic COVID-19 carrier - would not provide a positive response to disease. This capability is why PCR is considered a binding standard in diagnostic tests. It is highly specific and highly sensitive, which is why it provides the best chance of detecting a pathogen.
Adam de la Zerda, founder and CEO of Visby, said: “We are excited about the FDA decision. The corona crisis has proven that we need accurate test results that are delivered quickly, so PCR is the right way to perform a corona test. "We are pleased that Visby's personal PCR device will now provide rapid and accurate testing to the lab workers who are at the forefront of the epidemic."
Itai Harel, managing partner of the Israeli Pitango Health Tech fund, which led the third round of investment in the company, said: "The infectious disease testing market is a $ 40 billion market, whose main technology for the past 25 years is PCR. Wisby is revolutionizing the world of "PCR as the smartphone has changed the world of computing, using a perishable, simple, fast and accurate handheld device, which allows tests to be performed with maximum accuracy, anywhere, and quickly."